Dpp3: from biomarker to therapeutic target of cardiovascular diseases

HIGHLIGHTS

  • who: Xing Tan and Wei-Zhong Wang from the of Turin, Italy have published the research: DPP3: From biomarker to therapeutic target of cardiovascular diseases, in the Journal: (JOURNAL)

SUMMARY

    Cardiovascular disease is a major cause of disability and premature death worldwide, taking the lives of 17.9 million people in 2019, of which 81% occur in developing countries, and over one-third are premature deaths. There are eight distinct subtypes in this family, including DPP1, DPP2, DPP3, DPP4, DPP6, DPP8, DPP9, and DPP10. The molecular weight of the purified DPP3 homologs is . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?